35Pharma

35Pharma is a biopharmaceutical company based in the United States. The company is privately held and employs 7 people. 35Pharma specializes in the design and development of biologics to treat pulmonary hypertension and musculoskeletal disorders. Their products are intended for patients suffering from these conditions. 35Pharma differentiates itself through its focus on biologics, a specialized area within the pharmaceutical industry. This targeted approach allows them to develop innovative therapies for specific medical needs. Potential customers can visit 35pharma.com for more information about the company and its products.

35Pharma is a biopharmaceutical company focused on designing and developing innovative biologics. The company's primary focus is on therapeutics related to the TGF-beta superfamily. 35Pharma is located at 750 St Laurent Boulevard Suite 101, Montreal, QC, H2Y 2Z4. The company operates within the healthcare, pharmaceuticals, and biotechnology industries. 35Pharma's team has extensive experience in drug development. The company is advancing its clinical pipeline, with a focus on pulmonary hypertension, cardiometabolic disease, and obesity. 35Pharma's competitive advantages include 24/7 support and over 15 years of experience. The company utilizes rational design, fueled by years of experience. 35Pharma has a highly qualified team of drug developers and company builders. The company has a track record of advancing complex biologics from discovery through clinical trials. The company's leadership team includes Ilia Tikhomirov, MBA, as Chief Executive Officer; Maureen O’Connor, PhD, as Chief Scientific Officer; and George Georges, MD, FCCP, ATSF, as Chief Medical Officer. Other key personnel include Monique Champagne, VP, Clinical Operations; Julia Schoelermann, PhD MBA, VP, Corporate Development; Gilles Tremblay, PhD, VP, Preclinical & Discovery; Caroline McNicoll, LLB, LLM, MBA, VP, General Counsel; and Thomas Loisel, PhD, VP, Manufacturing. 35Pharma's values include connecting science and passion to deliver transformative therapies. The company is driven by a mission to radically transform patients’ lives. They embrace change and experimentation, operate with a sense of urgency, and strive for high performance. The company emphasizes integration. Contact information includes the email addresses [email protected], [email protected], and [email protected]. The company does not list a phone number.